These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16862463)

  • 1. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection.
    Stolz D; Christ-Crain M; Gencay MM; Bingisser R; Huber PR; Müller B; Tamm M
    Swiss Med Wkly; 2006 Jul; 136(27-28):434-40. PubMed ID: 16862463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.
    Prat C; Domínguez J; Rodrigo C; Giménez M; Azuara M; Jiménez O; Galí N; Ausina V
    Pediatr Infect Dis J; 2003 Nov; 22(11):963-8. PubMed ID: 14614368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
    Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
    BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial.
    Baer G; Baumann P; Buettcher M; Heininger U; Berthet G; Schäfer J; Bucher HC; Trachsel D; Schneider J; Gambon M; Reppucci D; Bonhoeffer JM; Stähelin-Massik J; Schuetz P; Mueller B; Szinnai G; Schaad UB; Bonhoeffer J
    PLoS One; 2013; 8(8):e68419. PubMed ID: 23936304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.
    Kim HS; Won S; Lee EK; Chun YH; Yoon JS; Kim HH; Kim JT
    Pediatr Pulmonol; 2016 Jan; 51(1):42-8. PubMed ID: 25832310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial.
    Fuchs A; Gotta V; Decker ML; Szinnai G; Baumann P; Bonhoeffer J; Ritz N;
    Clin Microbiol Infect; 2018 Dec; 24(12):1341.e1-1341.e7. PubMed ID: 29555393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Procalcitonin as a biomarker in infections].
    Christ-Crain M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center.
    Galetto-Lacour A; Zamora SA; Gervaix A
    Pediatrics; 2003 Nov; 112(5):1054-60. PubMed ID: 14595045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?
    Delèvaux I; André M; Colombier M; Albuisson E; Meylheuc F; Bègue RJ; Piette JC; Aumaître O
    Ann Rheum Dis; 2003 Apr; 62(4):337-40. PubMed ID: 12634233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients].
    Schmidt N; Palma J; King A; Santolaya ME
    Rev Med Chil; 2007 Aug; 135(8):982-9. PubMed ID: 17989854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.
    Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Baechli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Schuetz P; Gaillat J; Regez K; Bossart R; Schild U; Müller B; Albrich WC;
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):51-60. PubMed ID: 22886090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients.
    Svaldi M; Hirber J; Lanthaler AI; Mayr O; Faes S; Peer E; Mitterer M
    Br J Haematol; 2001 Oct; 115(1):53-7. PubMed ID: 11722409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
    Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
    Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.